Tania Small on Blogger

About Tania Small

With extensive expertise in drug development and medical affairs, Dr. Tania Small serves as head of the Medical Affairs organization and Senior Vice President at BMS. Her role encompasses overseeing the comprehensive medical strategy to develop and bring BMS' medicines to market. This includes driving early and late-stage medical evidence generation across all therapeutic areas, enhancing scientific and medical communication, managing access strategies, and fostering scientific engagement and partnerships. Her goal is to profoundly impact patient lives and influence the healthcare landscape. Prior to her current role, Dr. Small served as Global Head of Hematology and Oncology Medical Affairs and Vice President at GSK. Her career spans leadership roles in biotech and pharmaceutical firms of varying sizes, specializing in drug development for rare diseases, benign and malignant hematology, oncology, and radiopharmaceuticals. Her extensive background in basic and clinical research covers oncology, hematology, and stem cell transplants. Dr. Small is also dedicated to advancing diversity, equity, and inclusion initiatives, which have resulted in high-performing teams under her guidance. Throughout her career, she has been recognized with prestigious awards such as the Tigerlily Maverick Award, Philadelphia Business Journal’s Diversity in Business Award, PharmaVoice’s Disrupters Award, and the Women of Color in Pharma Trailblazer Award. She has also received accolades including a teaching award for fellows and a genetics research fellowship award. As a pediatric hematologist/ oncologist, Dr. Tania Small did both residency and fellowship at New York Presbyterian, Columbia University and earned her medical degree with distinction in hematology from the Albert Einstein College of Medicine.